Exact Mass: 305.1375

Exact Mass Matches: 305.1375

Found 121 metabolites which its exact mass value is equals to given mass value 305.1375, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Imazamox

5-(Methoxymethyl)-2-[4-methyl-5-oxo-4-(propan-2-yl)-4,5-dihydro-1H-imidazol-2-yl]pyridine-3-carboxylic acid

C15H19N3O4 (305.1375)


2-(4-isopropyl-4-methyl-5-oxo-4,5-dihydro-1H-imidazol-2-yl)-5-(methoxymethyl)nicotinic acid is a pyridinemonocarboxylic acid that is nicotinic acid which is substituted substituted at position 5 by a methoxymethyl group and at position 2 by a 4,5-dihydro-1H-imidazol-2-yl group, that in turn is substituted by isopropyl, methyl, and oxo groups at positions 4, 4, and 5, respectively. It is a pyridinemonocarboxylic acid, an ether, an imidazolone and a member of imidazolines. Imazamox is a member of the imidazolinone class of herbicides. It is registered for post-emergence control of broadleaf weeds and grass in alfalfa, edible legumes and soybeans. It is a systemic herbicide that moves throughout the plant tissue and prevents plants from producing an essential enzyme, acetolactate synthase (ALS), which is not found in animals. This enzyme is key for the biosynthesis of branched chain amino acids. Susceptible plants will stop growing soon after treatment, but plant death and decomposition will occur over several weeks.

   

Zaleplon

N-(3-(3-Cyanopyrazolo(1,5-a)pyrimidin-7-yl)phenyl)-N-ethylacetamide

C17H15N5O (305.1277)


Zaleplon is a sedative/hypnotic, mainly used for insomnia. It is known as a nonbenzodiazepine hypnotic. Zaleplon interacts with the GABA receptor complex and shares some of the pharmacological properties of the benzodiazepines. Zaleplon is a schedule IV drug in the United States. D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives N - Nervous system > N05 - Psycholeptics > N05C - Hypnotics and sedatives > N05CF - Benzodiazepine related drugs D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018757 - GABA Modulators C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic D002491 - Central Nervous System Agents > D000927 - Anticonvulsants

   

Benzosimuline

8,13,17,17-tetramethyl-18-oxa-8-azatetracyclo[8.8.0.0²,⁷.0¹¹,¹⁶]octadeca-1(10),2,4,6,11(16),12,14-heptaen-9-one

C20H19NO2 (305.1416)


Benzosimuline is found in fruits. Benzosimuline is an alkaloid from the bark of Zanthoxylum simulans (Szechuan pepper

   

Threonyltryptophan

(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-(1H-indol-3-yl)propanoic acid

C15H19N3O4 (305.1375)


Threonyltryptophan is a dipeptide composed of threonine and tryptophan. It is an incomplete breakdown product of protein digestion or protein catabolism. Dipeptides are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Some dipeptides are known to have physiological or cell-signalling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

   

Tryptophyl-Threonine

2-{[2-amino-1-hydroxy-3-(1H-indol-3-yl)propylidene]amino}-3-hydroxybutanoate

C15H19N3O4 (305.1375)


Tryptophyl-Threonine is a dipeptide composed of tryptophan and threonine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

   

(2S,3R)-3-hydroxy-2-methylpentanedioylcarnitine

3-[(4-carboxy-3-hydroxy-4-methylbutanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C13H23NO7 (305.1474)


(2S,3R)-3-hydroxy-2-methylpentanedioylcarnitine is an acylcarnitine. More specifically, it is an (2S,3R)-3-hydroxy-2-methylpentanedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (2S,3R)-3-hydroxy-2-methylpentanedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine (2S,3R)-3-hydroxy-2-methylpentanedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

3-Hydroxyhexanedioylcarnitine

3-[(5-carboxy-3-hydroxypentanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C13H23NO7 (305.1474)


3-hydroxyhexanedioylcarnitine is an acylcarnitine. More specifically, it is an 3-hydroxyhexanedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 3-hydroxyhexanedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 3-hydroxyhexanedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

2-Ethyl-2-hydroxybutanedioylcarnitine

3-[(3-carboxy-3-ethyl-3-hydroxypropanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C13H23NO7 (305.1474)


2-Ethyl-2-hydroxybutanedioylcarnitine is an acylcarnitine. More specifically, it is an 2-ethyl-2-hydroxybutanedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 2-Ethyl-2-hydroxybutanedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 2-Ethyl-2-hydroxybutanedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

1-(1-Naphthylmethyl)-1,2,3,4-tetrahydroisoquinoline-6,7-diol

1-[(naphthalen-1-yl)methyl]-1,2,3,4-tetrahydroisoquinoline-6,7-diol

C20H19NO2 (305.1416)


   

1-(Naphthalen-2-ylmethyl)-1,2,3,4-tetrahydroisoquinoline-6,7-diol

1-[(naphthalen-2-yl)methyl]-1,2,3,4-tetrahydroisoquinoline-6,7-diol

C20H19NO2 (305.1416)


   

6-[5-(4-Carbamimidoylphenyl)-2-furyl]pyridine-3-carboxamidine

6-[5-(4-carbamimidoylphenyl)furan-2-yl]pyridine-3-carboximidamide

C17H15N5O (305.1277)


   

Threoninyl-Tryptophan

2-[(2-amino-1,3-dihydroxybutylidene)amino]-3-(1H-indol-3-yl)propanoic acid

C15H19N3O4 (305.1375)


   

1-(1-isoquinolyl)-2-methylpropyl benzoate

1-(1-isoquinolyl)-2-methylpropyl benzoate

C20H19NO2 (305.1416)


   
   
   
   
   
   
   
   

Imazamox

Imazamox

C15H19N3O4 (305.1375)


2-(4-isopropyl-4-methyl-5-oxo-4,5-dihydro-1H-imidazol-2-yl)-5-(methoxymethyl)nicotinic acid is a pyridinemonocarboxylic acid that is nicotinic acid which is substituted substituted at position 5 by a methoxymethyl group and at position 2 by a 4,5-dihydro-1H-imidazol-2-yl group, that in turn is substituted by isopropyl, methyl, and oxo groups at positions 4, 4, and 5, respectively. It is a pyridinemonocarboxylic acid, an ether, an imidazolone and a member of imidazolines. Imazamox is a member of the imidazolinone class of herbicides. It is registered for post-emergence control of broadleaf weeds and grass in alfalfa, edible legumes and soybeans. It is a systemic herbicide that moves throughout the plant tissue and prevents plants from producing an essential enzyme, acetolactate synthase (ALS), which is not found in animals. This enzyme is key for the biosynthesis of branched chain amino acids. Susceptible plants will stop growing soon after treatment, but plant death and decomposition will occur over several weeks.

   

Zaleplon

Zaleplon

C17H15N5O (305.1277)


D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives N - Nervous system > N05 - Psycholeptics > N05C - Hypnotics and sedatives > N05CF - Benzodiazepine related drugs D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018757 - GABA Modulators C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic D002491 - Central Nervous System Agents > D000927 - Anticonvulsants

   

1H-1,2,4-Triazole-1-propanoic acid, 3-ethyl-4,5-dihydro-5-oxo-4-(2-phenoxyethyl)-

1H-1,2,4-Triazole-1-propanoic acid, 3-ethyl-4,5-dihydro-5-oxo-4-(2-phenoxyethyl)-

C15H19N3O4 (305.1375)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

THR-TRP

2-[2-amino-3-(1H-indol-3-yl)propanamido]-3-hydroxybutanoic acid

C15H19N3O4 (305.1375)


A dipeptide composed of L-threonine and L-tryptophan joined by a peptide linkage.

   

TRP-THR

2-(2-amino-3-hydroxybutanamido)-3-(1H-indol-3-yl)propanoic acid

C15H19N3O4 (305.1375)


   

benzosimuline

8,13,17,17-tetramethyl-18-oxa-8-azatetracyclo[8.8.0.0^{2,7}.0^{11,16}]octadeca-1(10),2,4,6,11(16),12,14-heptaen-9-one

C20H19NO2 (305.1416)


   

2-chloro-N-(2-(diethylamino)ethyl)quinoline-4-carboxamide

2-chloro-N-(2-(diethylamino)ethyl)quinoline-4-carboxamide

C16H20ClN3O (305.1295)


   

tert-butyl 2-[hydroxy(dimethyl)silyl]-5-methylindole-1-carboxylate

tert-butyl 2-[hydroxy(dimethyl)silyl]-5-methylindole-1-carboxylate

C16H23NO3Si (305.1447)


   
   

3-Methyl-2-(4-propylphenyl)quinoline-4-carboxylic acid

3-Methyl-2-(4-propylphenyl)quinoline-4-carboxylic acid

C20H19NO2 (305.1416)


   

5-([1,2,4]TRIAZOLO[1,5-A]PYRIDIN-6-YL)-4-METHYL-1-(M-TOLYL)-1H-IMIDAZOL-2(3H)-ONE

5-([1,2,4]TRIAZOLO[1,5-A]PYRIDIN-6-YL)-4-METHYL-1-(M-TOLYL)-1H-IMIDAZOL-2(3H)-ONE

C17H15N5O (305.1277)


   

(3-(3-(ETHOXYCARBONYL)PIPERIDINE-1-CARBONYL)PHENYL)BORONIC ACID

(3-(3-(ETHOXYCARBONYL)PIPERIDINE-1-CARBONYL)PHENYL)BORONIC ACID

C15H20BNO5 (305.1434)


   
   

ethyl 2-methyl-4,5-diphenyl-1H-pyrrole-3-carboxylate

ethyl 2-methyl-4,5-diphenyl-1H-pyrrole-3-carboxylate

C20H19NO2 (305.1416)


   

2,4-bis(2-methylphenoxy)aniline

2,4-bis(2-methylphenoxy)aniline

C20H19NO2 (305.1416)


   

[6-ethoxy-1-[(2-methylpropan-2-yl)oxycarbonyl]indol-2-yl]boronic acid

[6-ethoxy-1-[(2-methylpropan-2-yl)oxycarbonyl]indol-2-yl]boronic acid

C15H20BNO5 (305.1434)


   

ethyl 2-methyl-1,5-diphenylpyrrole-3-carboxylate

ethyl 2-methyl-1,5-diphenylpyrrole-3-carboxylate

C20H19NO2 (305.1416)


   

5-(4-chlorophenyl)-9-methyl-1,3,5-triazaspiro[5.5]undeca-1,3-diene-2,4-diamine

5-(4-chlorophenyl)-9-methyl-1,3,5-triazaspiro[5.5]undeca-1,3-diene-2,4-diamine

C15H20ClN5 (305.1407)


   

benzoic acid, diphenylmethanamine

benzoic acid, diphenylmethanamine

C20H19NO2 (305.1416)


   

Ethyl 5-((tert-butoxycarbonyl)amino)pyrazolo[1,5-a]pyridine-3-carboxylate

Ethyl 5-((tert-butoxycarbonyl)amino)pyrazolo[1,5-a]pyridine-3-carboxylate

C15H19N3O4 (305.1375)


   

4-(Dimethylamino)phenyldiphenylphosphine

4-(Dimethylamino)phenyldiphenylphosphine

C20H20NP (305.1333)


   

boc-dl-7-azatryptophan

boc-dl-7-azatryptophan

C15H19N3O4 (305.1375)


   

2-(4-TERT-BUTYLPHENYL)QUINOLINE-4-CARBOXYLICACID

2-(4-TERT-BUTYLPHENYL)QUINOLINE-4-CARBOXYLICACID

C20H19NO2 (305.1416)


   

tert-Butyl 3-morpholin-3-yl-propionate oxalate

tert-Butyl 3-morpholin-3-yl-propionate oxalate

C13H23NO7 (305.1474)


   

(4-(3-(Ethoxycarbonyl)piperidine-1-carbonyl)phenyl)boronic acid

(4-(3-(Ethoxycarbonyl)piperidine-1-carbonyl)phenyl)boronic acid

C15H20BNO5 (305.1434)


   

Benzyl 4-((trimethylsilyl)oxy)-5,6-dihydropyridine-1(2H)-carboxylate

Benzyl 4-((trimethylsilyl)oxy)-5,6-dihydropyridine-1(2H)-carboxylate

C16H23NO3Si (305.1447)


   

sodium,1,1-biphenyl,naphthalene

sodium,1,1-biphenyl,naphthalene

C22H18Na+ (305.1306)


   

2-Acetamido-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoic acid

2-Acetamido-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoic acid

C15H20BNO5 (305.1434)


   

(S)-1-(2-(DIPHENYLPHOSPHINO)PHENYL)ETHANAMINE

(S)-1-(2-(DIPHENYLPHOSPHINO)PHENYL)ETHANAMINE

C20H20NP (305.1333)


   

N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-N-(1,1,2,2,2-pentadeuterioethyl)acetamide

N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-N-(1,1,2,2,2-pentadeuterioethyl)acetamide

C17H15N5O (305.1277)


   

1-[4-(aminomethyl)phenyl]-N,N-dimethylpiperidin-4-amine,dihydrochloride

1-[4-(aminomethyl)phenyl]-N,N-dimethylpiperidin-4-amine,dihydrochloride

C14H25Cl2N3 (305.1425)


   

4,4-Dimethoxy-triphenylamine

4,4-Dimethoxy-triphenylamine

C20H19NO2 (305.1416)


   

1-[5-(2-Benzyl-2H-indazol-3-yl)-1,2,4-oxadiazol-3-yl]methanamine

1-[5-(2-Benzyl-2H-indazol-3-yl)-1,2,4-oxadiazol-3-yl]methanamine

C17H15N5O (305.1277)


   

1-[5-(1-Benzyl-1H-indazol-3-yl)-1,2,4-oxadiazol-3-yl]methanamine

1-[5-(1-Benzyl-1H-indazol-3-yl)-1,2,4-oxadiazol-3-yl]methanamine

C17H15N5O (305.1277)


   

9-benzyl-2,3,4,9-tetrahydro-1H-carbazole-8-carboxylic acid

9-benzyl-2,3,4,9-tetrahydro-1H-carbazole-8-carboxylic acid

C20H19NO2 (305.1416)


   

1-N-(4-Sulfamoylphenyl-ethyl)-2,4,6-trimethylpyridinium

1-N-(4-Sulfamoylphenyl-ethyl)-2,4,6-trimethylpyridinium

C16H21N2O2S+ (305.1324)


   

Anilinomethyl gluco-phenylimidazole

Anilinomethyl gluco-phenylimidazole

C15H19N3O4 (305.1375)


   

6-Amino-4-(2-phenylethyl)-1,7-dihydro-8H-imidazo[4,5-G]quinazolin-8-one

6-Amino-4-(2-phenylethyl)-1,7-dihydro-8H-imidazo[4,5-G]quinazolin-8-one

C17H15N5O (305.1277)


   

3-Hydroxyhexanedioylcarnitine

3-Hydroxyhexanedioylcarnitine

C13H23NO7 (305.1474)


   

2-Ethyl-2-hydroxybutanedioylcarnitine

2-Ethyl-2-hydroxybutanedioylcarnitine

C13H23NO7 (305.1474)


   

(2S,3R)-3-hydroxy-2-methylpentanedioylcarnitine

(2S,3R)-3-hydroxy-2-methylpentanedioylcarnitine

C13H23NO7 (305.1474)


   

[(E)-(1,3-diphenylpyrazol-4-yl)methylideneamino]urea

[(E)-(1,3-diphenylpyrazol-4-yl)methylideneamino]urea

C17H15N5O (305.1277)


   

N-(2-furanylmethyl)-1-(phenylmethyl)-4-pyrazolo[3,4-d]pyrimidinamine

N-(2-furanylmethyl)-1-(phenylmethyl)-4-pyrazolo[3,4-d]pyrimidinamine

C17H15N5O (305.1277)


   

N-(2-ethoxyphenyl)-[1,2,4]triazolo[4,3-a]quinoxalin-4-amine

N-(2-ethoxyphenyl)-[1,2,4]triazolo[4,3-a]quinoxalin-4-amine

C17H15N5O (305.1277)


   

7-(4-Methoxyphenyl)-5-phenyl-1,7-dihydrotetrazolo[1,5-a]pyrimidine

7-(4-Methoxyphenyl)-5-phenyl-1,7-dihydrotetrazolo[1,5-a]pyrimidine

C17H15N5O (305.1277)


   

7-(2-Methoxyphenyl)-5-phenyl-1,7-dihydrotetrazolo[1,5-a]pyrimidine

7-(2-Methoxyphenyl)-5-phenyl-1,7-dihydrotetrazolo[1,5-a]pyrimidine

C17H15N5O (305.1277)


   

4-(2,3-Dihydroindol-1-ylmethyl)-7-ethyl-1-benzopyran-2-one

4-(2,3-Dihydroindol-1-ylmethyl)-7-ethyl-1-benzopyran-2-one

C20H19NO2 (305.1416)


   

N-[1-(5,6-dicyano-3-methyl-2-pyrazinyl)ethyl]-N-phenylacetamide

N-[1-(5,6-dicyano-3-methyl-2-pyrazinyl)ethyl]-N-phenylacetamide

C17H15N5O (305.1277)


   

L-Tryptophyl-L-threonine

L-Tryptophyl-L-threonine

C15H19N3O4 (305.1375)


   

N-[(E)-[2-(1H-imidazol-2-yl)-1-phenylethylidene]amino]pyridine-4-carboxamide

N-[(E)-[2-(1H-imidazol-2-yl)-1-phenylethylidene]amino]pyridine-4-carboxamide

C17H15N5O (305.1277)


   
   
   

N(6)-L-homocysteinyl-N(2)-acetyl-L-lysine

N(6)-L-homocysteinyl-N(2)-acetyl-L-lysine

C12H23N3O4S (305.1409)


   
   

L-homocysteinyl-N(6)-acetyl-L-lysine

L-homocysteinyl-N(6)-acetyl-L-lysine

C12H23N3O4S (305.1409)


   
   

N-(2-aminophenyl)-2-anilino-5-pyrimidinecarboxamide

N-(2-aminophenyl)-2-anilino-5-pyrimidinecarboxamide

C17H15N5O (305.1277)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

3-[3-Ethyl-5-oxo-4-(2-phenoxyethyl)-1,2,4-triazol-1-yl]propanoic acid

3-[3-Ethyl-5-oxo-4-(2-phenoxyethyl)-1,2,4-triazol-1-yl]propanoic acid

C15H19N3O4 (305.1375)


   

Tryptophylthreonine

Tryptophylthreonine

C15H19N3O4 (305.1375)


   

Threoninyl-Tryptophan

Threoninyl-Tryptophan

C15H19N3O4 (305.1375)


   

6,6,9,12-tetramethylisochromeno[4,3-c]quinolin-11-one

6,6,9,12-tetramethylisochromeno[4,3-c]quinolin-11-one

C20H19NO2 (305.1416)


   

(2z)-3-methyl-9-oxo-n-(2-sulfoethyl)dec-2-enimidic acid

(2z)-3-methyl-9-oxo-n-(2-sulfoethyl)dec-2-enimidic acid

C13H23NO5S (305.1297)


   

3-methyl-9-oxo-n-(2-sulfoethyl)dec-2-enimidic acid

3-methyl-9-oxo-n-(2-sulfoethyl)dec-2-enimidic acid

C13H23NO5S (305.1297)


   

2-amino-3-(c-hydroxycarbonimidoyl)-3-(4-methoxy-1-methylquinolin-4-yl)propanoic acid

2-amino-3-(c-hydroxycarbonimidoyl)-3-(4-methoxy-1-methylquinolin-4-yl)propanoic acid

C15H19N3O4 (305.1375)